Literature DB >> 6762701

Plasma protein binding and therapeutic drug monitoring.

M Rowland.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6762701     DOI： 10.1097/00007691-198001000-00005

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  27 in total

1.  Factors affecting the determination of unbound carbamazepine concentrations in plasma.

Authors:  J J Lohman; F W Merkus; G M Costongs; E P Hegtermans; P M Hooymans
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

Review 2.  The use of kinetic-dynamic interactions in the evaluation of drugs.

Authors:  D B Campbell
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  Plasma protein binding of drugs in pregnancy and in neonates.

Authors:  L J Notarianni
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

4.  Role of lipoproteins in the plasma binding of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin.

Authors:  N Simon; E Dailly; O Combes; E Malaurie; M Lemaire; J P Tillement; S Urien
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

5.  Theoretical study of the influence of the circadian rhythm of plasma protein binding on cisplatin area under the curve.

Authors:  B Hecquet; M Sucche
Journal:  J Pharmacokinet Biopharm       Date:  1986-02

6.  Plasma protein binding of dipyrone metabolites in man.

Authors:  E Zylber-Katz; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.

Authors:  M Oellerich; H Müller-Vahl
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

8.  Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels.

Authors:  H Nau; W Luck; W Kuhnz
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

9.  Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing.

Authors:  W G Rapeport; A D Mendelow; G French; P MacPherson; E Teasdale; E Agnew; G G Thompson; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

Review 10.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.